Lonza Group AG

SWX:LONN Stock Report

Market Cap: CHF 37.1b

Lonza Group Future Growth

Future criteria checks 3/6

Lonza Group is forecast to grow earnings and revenue by 17.2% and 10.6% per annum respectively. EPS is expected to grow by 17.4% per annum. Return on equity is forecast to be 16.8% in 3 years.

Key information

17.2%

Earnings growth rate

17.38%

EPS growth rate

Life Sciences earnings growth19.2%
Revenue growth rate10.6%
Future return on equity16.75%
Analyst coverage

Good

Last updated04 Sep 2026

Recent future growth updates

Recent updates

Narrative Update • Jul 24

LONN: Bioprocessing Recovery And ADC Deals Will Support Future Upside

Lonza Group's updated analyst price target edges higher to CHF 678, supported by broader target increases across the Street toward CHF 640 to CHF 760 as analysts factor in revised assumptions on fair value, discount rate, revenue growth, profit margin and future P/E levels. Analyst Commentary Recent research on Lonza Group points to a mixed but generally constructive stance, with several price target adjustments clustering between CHF 590 and CHF 760.
Narrative Update • Jun 24

LONN: Bioprocessing Recovery And ADC Licensing Pipeline Will Drive Future Upside

Analysts have trimmed their average price target for Lonza Group to roughly CHF 663 from about CHF 664, reflecting slightly higher discount rate assumptions and updated expectations for revenue growth, profit margins, and future P/E multiples in light of recent research that includes reduced targets of CHF 590 and CHF 656 from major banks. Analyst Commentary Recent research on Lonza Group shows that analysts are adjusting their models and price targets while still weighing the company against broader views on life science tools, bioprocessing and quality assurance demand.
Narrative Update • Jun 06

LONN: Recovery In Life Science Tools Demand Will Drive Future Upside

Narrative Update: Lonza Group Analysts have trimmed their blended price target for Lonza Group by about CHF 13 to reflect lower fair value estimates and a higher discount rate, even as they point to early signs of recovery in life science tools demand and resilient profitability expectations. Analyst Commentary Recent research updates show that price targets for Lonza Group have been revised lower, even as some analysts highlight early recovery signs in key end markets.
Analysis Article • Apr 09

Lonza Group's (VTX:LONN) Solid Earnings Are Supported By Other Strong Factors

Lonza Group AG ( VTX:LONN ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests...
Analysis Article • Dec 22

Is There Now An Opportunity In Lonza Group AG (VTX:LONN)?

Lonza Group AG ( VTX:LONN ) saw significant share price movement during recent months on the SWX, rising to highs of...
Analysis Article • Dec 01

We Think Lonza Group (VTX:LONN) Is Taking Some Risk With Its Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Oct 24

Investors Interested In Lonza Group AG's (VTX:LONN) Earnings

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 19x, you may consider...
Narrative Update • Sep 19

Vacaville And Visp Facilities Will Secure Future Biologics Demand

Given the absence of analyst reasoning, the consensus analyst price target for Lonza Group saw only a marginal increase from CHF665.36 to CHF676.18 alongside minimal changes in key valuation metrics such as future P/E and discount rate, indicating steady market expectations and a broadly unchanged fair value outlook. What's in the News Lonza entered a seven-year manufacturing agreement with Avidity Biosciences for commercial drug substance and product, with a minimum purchase commitment of approximately $620 million between 2026 and 2028.
User avatar
New Narrative • Feb 02

CDMO Focus And Vacaville Acquisition To Drive Operational Improvements By 2025

Focus on CDMO business and Vacaville acquisition to drive revenue growth and boost sales.

Earnings and Revenue Growth Forecasts

SWX:LONN - Analysts future estimates and past financials data (CHF Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20288,9161,6978752,37320
12/31/20277,9531,4376372,10523
12/31/20267,1291,2194941,80823
6/30/20266,8711,0811501,435N/A
3/31/20266,701995-361,296N/A
12/31/20256,531909-2221,156N/A
6/30/20255,457668-3751,147N/A
3/31/20255,469635-2861,211N/A
12/31/20245,480601-1981,274N/A
9/30/20246,635605-1141,399N/A
6/30/20246,696573-301,524N/A
3/31/20246,707614-1691,456N/A
12/31/20236,717654-3091,388N/A
9/30/20236,518892-5321,239N/A
6/30/20236,3191,129-7561,089N/A
3/31/20236,2711,172-8281,055N/A
12/31/20226,2231,215-9011,020N/A
9/30/20226,0361,062-819994N/A
6/30/20225,849909-737968N/A
3/31/20225,629792-4501,093N/A
12/31/20215,409674-1631,217N/A
9/30/20215,108612-21,233N/A
6/30/20214,8075501591,249N/A
3/31/20214,6586401501,190N/A
12/31/20204,5087301401,130N/A
9/30/20203,1356562361,181N/A
6/30/20203,4746963441,241N/A
3/31/20203,841672N/A1,109N/A
12/31/20194,207647N/A977N/A
9/30/20195,821710N/AN/AN/A
6/30/20195,722658N/A821N/A
3/31/20195,632657N/A952N/A
12/31/20185,542655N/A1,082N/A
6/30/20185,034826N/A860N/A
3/31/20184,791745N/A851N/A
12/31/20174,548664N/A841N/A
9/30/20174,758527N/A798N/A
6/30/20174,423334N/A738N/A
3/31/20174,278318N/A745N/A
12/31/20164,132301N/A752N/A
9/30/20164,025331N/A779N/A
6/30/20163,918360N/A805N/A
3/31/20163,861319N/A773N/A
12/31/20153,803277N/A741N/A
9/30/20153,774243N/A710N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LONN's forecast earnings growth (17.2% per year) is above the savings rate (0.6%).

Earnings vs Market: LONN's earnings (17.2% per year) are forecast to grow faster than the Swiss market (12.2% per year).

High Growth Earnings: LONN's earnings are forecast to grow, but not significantly.

Revenue vs Market: LONN's revenue (10.6% per year) is forecast to grow faster than the Swiss market (5.2% per year).

High Growth Revenue: LONN's revenue (10.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: LONN's Return on Equity is forecast to be low in 3 years time (16.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/14 03:47
End of Day Share Price 2026/09/11 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lonza Group AG is covered by 52 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charles PitmanBarclays
Sebastian BrayBerenberg
Xian DengBerenberg